glp 1 side effects skin GLP-1 Dermatologic Effects: What Clinicians Should Know Ablon 2_EDITED_v1

Exhibit III Lexarias GLP-1 Agonist Human Studies Source: Lexaria Bioscience September 2025 Corporate Presentation Capital Raises September $4.0 Million Raise On September 26 th , Lexaria announced a $4.0 million registered direct offering priced at the market

Replenza pricing and availability Price matters

Verify specific state availability during enrollment process on MEDVi website

Since the 2000s, incretin-based therapies for diabetes and obesity have become the focus of research and clinical practice

They were also asked about GLP-RA use, including the specific drug, reasons for use, duration, side effects, and expected period of future use

10.2337/dc10-1900 24 GallwitzB.GuzmanJ.DottaF.GuerciB.SimR.BassonB